Sign Up to like & get
recommendations!
0
Published in 2025 at "Annals of Clinical and Translational Neurology"
DOI: 10.1002/acn3.70051
Abstract: This phase 3b, open‐label, randomized ADAPT NXT study investigated the efficacy, safety, and tolerability of efgartigimod administered in either a fixed cycles dosing regimen (3 cycles of 4 once‐weekly infusions, with 4 weeks between cycles) or a…
read more here.
Keywords:
cycles every;
every week;
nxt fixed;
adapt nxt ... See more keywords